News for NeuroOne Medical Technologies Corporation (NMTCD)

NeuroOne's OneRF® Ablation System has been instrumental in achieving complete seizure freedom for a patient over one year. FDA 510(k)-cleared device unique

EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation ( NMTC) ("NeuroOne" or the "Company"), a medical technology c

**media[640810]**

May 13, 2025 / 12:30PM GMTOperator Good day, ladies and gentlemen. Welcome to the second-quarter of fiscal year 2025 financial results conference call for Neuro

The following slide deck was published by NeuroOne Medical Technologies Corporation in conjunction with their 2025 Q1 earnings call.

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q2 2025 Earnings Conference Call May 13, 2025 8:30 AM ETCompany ParticipantsDave Rosa – CEORon...

NeuroOne Medical Technologies (NMTC) names Dr. Parag Patil as Chief Medical Advisor. Dr. Patil brings 20 years of experience in neurosurgery and enginee

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) will release its fiscal second quarter 2025 financial results on May 13, 2025, before the market ope

EDEN PRAIRIE, Minn., May 01, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation ( NMTC) ("NeuroOne" or the "Company"), a medical technology co

NeuroOne Medical Technologies (NMTC) has submitted its 510(k) application to the FDA for the OneRF® Trigeminal Nerve Ablation System ahead of schedule.

Multi-Contact Probe Provides Alternative to Pharmaceutical and Invasive Surgical Treatments Submission Completed Earlier Than Anticipated EDEN PRAIRIE, Minn.,

NeuroOne Medical Technologies Corporation (NMTC) has recently achieved several key milestones, according to a letter from CEO Dave Rosa to shareholders. The com

\n NeuroOne Medical Technologies (NMTC) secured $8.3 million in funding, ensuring operations through fiscal 2026. The company expanded its partnership with

Company Now Fully Funded Through at least Fiscal 2026; Company Confirms No Material Impact from Global Tariffs EDEN PRAIRIE, Minn., April 16, 2025 (GLOBE NEW

Pediatric Patient Treated with OneRF® Ablation System Goes From Up to 10 Nightly Seizures to Zero EDEN PRAIRIE, Minn., April 14, 2025 (GLOBE NEWSWIRE) -- Ne

U.S. stocks traded lower midway through trading, with the Dow Jones index dipping more than 1,100 points on Friday. Beijing unveiled a retaliatory 34% tariff on...

NeuroOne Medical Technologies Corporation (NMTC) initiates a public offering to raise $8 million for general working capital. Analysts set a one-year ta

EDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation ( NMTC) (the ”œCompany”), a medical technology company fo